Medipal Holdings Valuation Multiples
Discover Medipal Holdings' revenue and EBITDA valuation multiples, acquisitions, and investment history.
Medipal Holdings Overview
About Medipal Holdings
Medipal Holdings Corp is engaged in the wholesale distribution of pharmaceuticals, cosmetics, daily necessities, and related products. The company operates through three reportable segments: Wholesale business of medical drugs; Cosmetics, Daily Necessities and OTC Pharmaceuticals Wholesale Business; and Wholesale of animal medicines and food processing ingredients. The Wholesale business of medical drugs segment targets hospitals, clinics, and dispensing pharmacies; the Cosmetics and OTC segment serves drug stores, home centers, convenience stores, and supermarkets; while the Wholesale of animal medicines and food processing ingredients segment supplies veterinary clinics, livestock and fisheries businesses, and food manufacturers.
Founded
1923
HQ
Employees
23.9K
Website
Financials (LTM)
EV
$2.8B
Valuation Multiples
Start free trial
Medipal Holdings Financials
Medipal Holdings reported last 12-month revenue of $24B and EBITDA of $448M.
In the same LTM period, Medipal Holdings generated $448M in EBITDA and $272M in net income.
Medipal Holdings P&L
In the most recent fiscal year, Medipal Holdings reported revenue of $24B and EBITDA of $624M.
Medipal Holdings is profitable as of last fiscal year, with gross margin of 7%, EBITDA margin of 3%, and net margin of 1%.
Financial data powered by Morningstar, Inc.
Medipal Holdings Stock Performance
Medipal Holdings has current market cap of $3.8B, and enterprise value of $2.8B.
Medipal Holdings' stock price is $18.37.
Medipal Holdings has an EPS (earnings per share) of $1.31.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2.8B | $3.8B | 1.1% | - | - | - | $1.31 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMedipal Holdings Valuation Multiples
Medipal Holdings trades at 0.1x EV/Revenue multiple, and 6.3x EV/EBITDA.
Medipal Holdings Financial Valuation Multiples
As of August 23, 2026, Medipal Holdings has market cap of $3.8B and EV of $2.8B.
Medipal Holdings has a P/E ratio of 13.8x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Medipal Holdings Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Medipal Holdings Margins & Growth Rates
Medipal Holdings grew revenue by 3% but EBITDA decreased by 28% in the last fiscal year.
In the most recent fiscal year, Medipal Holdings reported gross margin of 7%, EBITDA margin of 3%, and net margin of 1%.
Medipal Holdings Margins
Medipal Holdings Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Medipal Holdings Operational KPIs
Medipal Holdings' revenue per employee in the last FY averaged $1.0M, while opex per employee averaged $0.1M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Medipal Holdings Competitors
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
This data is available for Pro users. Sign up to see all Medipal Holdings competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Medipal Holdings
Medipal Holdings has acquired 1 company to date.
Last acquisition by Medipal Holdings was on July 24th 2024. Medipal Holdings acquired Presus Cube for $24M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by Medipal Holdings
| Description | Presus Cube is a provider of pharmacy management software and data analytics services. The platform supports inventory tracking, prescription processing, billing integration, and operational standardization for independent pharmacies. Operating in the US, it offers consulting for regulatory compliance and performance benchmarking to streamline daily workflows. |
| HQ Country |  |
| HQ City | Tokyo |
| Deal Date | 24 Jul 2024 |
| Valuation | $24M |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Medipal Holdings acquisitions and their M&A valuation multiples. Start Free Trial | |
Investments by Medipal Holdings
Medipal Holdings has invested in 4 companies to date.
Latest investment by Medipal Holdings was on June 11th 2021. Medipal Holdings invested in Heartseed in their $37M Series C round (EV/Revenue multiple available to Pro users).
Latest Investments by Medipal Holdings
| Description | Heartseed Inc is a Japanese biotechnology company focused on developing and commercializing regenerative medicine treatments for severe heart failure. The company's product candidate, HS-001, involves transplanting clusters of purified heart muscle cells derived from iPSCs to the patient's heart to treat heart failure, especially Heart Failure with reduced Left Ventricular Ejection Fraction (HFrEF), including conditions such as Dilated Cardiomyopathy, Old Myocardial Infarction, and Dilated phase of Hypertrophic Cardiomyopathy. | Heartseed Inc is a Japanese biotechnology company focused on developing and commercializing regenerative medicine treatments for severe heart failure. The company's product candidate, HS-001, involves transplanting clusters of purified heart muscle cells derived from iPSCs to the patient's heart to treat heart failure, especially Heart Failure with reduced Left Ventricular Ejection Fraction (HFrEF), including conditions such as Dilated Cardiomyopathy, Old Myocardial Infarction, and Dilated phase of Hypertrophic Cardiomyopathy. | FunPep Co Ltd is a biotechnology company focused on the functions of peptides to develop business from cosmetics to medical devices and pharmaceutical products. The company develops drugs related to the intractable peptic ulcer disease. The Group operates in a single segment, which is the research and development of pharmaceuticals. | CLIPLA is a Tokyo-based cloud provider of electronic medical records for Japanese hospitals. Its modular products capture patient data across departments with low setup costs. The system streamlines workflows for doctors, nurses, and staff through secure data storage and retrieval. | |
| HQ Country | | | | | |
| HQ City | Tokyo | Tokyo | Tokyo | Tokyo | |
| Deal Date | 11 Jun 2021 | 10 Mar 2020 | 5 Oct 2018 | 13 Mar 2018 | |
| Round | Series C | Strategic investment | Seed | Strategic investment | |
| Raised | $37M | $900K | $4M | $4M | |
| Investors | SBI Holdings; Medical Incubator Japan; UTokyo Innovation Platform; Sumitomo Mitsui Trust Investment; Nissay Capital; Keio Innovation Initiative; ITOCHU Chemical Frontier; Medipal Holdings; SMBC Venture Capital | ITOCHU Chemical Frontier; Medipal Holdings | FANCL; Shionogi; Bio-sight Capital; Mizuho Capital; Morishita Jintan Co; Sumitomo Pharma; Medipal Holdings | MTI Ltd.; Medipal Holdings | |
| Valuation | undisclosed | undisclosed | undisclosed | undisclosed | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all Medipal Holdings investments and their VC round multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Medipal Holdings
| When was Medipal Holdings founded? | Medipal Holdings was founded in 1923. |
| Where is Medipal Holdings headquartered? | Medipal Holdings is headquartered in Japan. |
| How many employees does Medipal Holdings have? | As of today, Medipal Holdings has over 23K employees. |
| Is Medipal Holdings publicly listed? | Yes, Medipal Holdings is a public company listed on Tokyo Stock Exchange. |
| What is the stock symbol of Medipal Holdings? | Medipal Holdings trades under 7459 ticker. |
| When did Medipal Holdings go public? | Medipal Holdings went public in 1995. |
| Who are competitors of Medipal Holdings? | Medipal Holdings main competitors include |
| What is the current market cap of Medipal Holdings? | Medipal Holdings' current market cap is $3.8B. |
| What is the current revenue of Medipal Holdings? | Medipal Holdings' last 12 months revenue is $24B. |
| What is the current revenue growth of Medipal Holdings? | Medipal Holdings revenue growth (NTM/LTM) is 3%. |
| What is the current EV/Revenue multiple of Medipal Holdings? | Current revenue multiple of Medipal Holdings is 0.1x. |
| What is the current EBITDA of Medipal Holdings? | Medipal Holdings' last 12 months EBITDA is $448M. |
| What is Medipal Holdings' EBITDA margin? | Medipal Holdings' last 12 months EBITDA margin is 2%. |
| What is the current EV/EBITDA multiple of Medipal Holdings? | Current EBITDA multiple of Medipal Holdings is 6.3x. |
| What is the current FCF of Medipal Holdings? | Medipal Holdings' last 12 months FCF is $505M. |
| What is Medipal Holdings' FCF margin? | Medipal Holdings' last 12 months FCF margin is 2%. |
| What is the current EV/FCF multiple of Medipal Holdings? | Current FCF multiple of Medipal Holdings is 5.6x. |
| How many companies Medipal Holdings has acquired to date? | As of August 2026, Medipal Holdings has acquired 1 company. |
| What was the largest acquisition by Medipal Holdings? | $24M acquisition of Presus Cube on 24th July 2024 was the largest M&A Medipal Holdings has done to date. |
| What companies Medipal Holdings acquired? | Medipal Holdings acquired Presus Cube. |
| In how many companies Medipal Holdings has invested to date? | As of August 2026, Medipal Holdings has invested in 4 companies. |
| What was the last Medipal Holdings investment? | On 11th June 2021 Medipal Holdings invested in Heartseed, participating in a $37M Series C round, alongside SBI Holdings, Medical Incubator Japan, UTokyo Innovation Platform, Sumitomo Mitsui Trust Investment, Nissay Capital, Keio Innovation Initiative, ITOCHU Chemical Frontier, and SMBC Venture Capital. |
| In what companies Medipal Holdings invested in? | Medipal Holdings invested in Scohia Pharma, Heartseed, CLIPLA, and FunPep Co. |
Lists including Medipal Holdings
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.